Matt grew up in Leeds, England and received his undergraduate degree (MChem) from the University of Sheffield in 2001. Following this he moved to the University of Bristol to undertake graduate studies under the tutelage of Professor Tim Gallagher, developing new C-glycosidation reaction and received his Ph.D. in 2005. Upon graduating, he came to the US as an American Heart Association Postdoctoral Researcher at Colorado State University working with Professor Tom Rovis on asymmetric anhydride desymmetrizations and applications towards ionomycin. After 3 years in the US, he returned to the UK in 2008 to perform a second postdoctoral stint with Professor Tony Barrett at Imperial college London developing novel cyclin dependent kinase (CDK) inhibitors. In 2009, Matt obtained his first faculty position at Queen’s University Belfast in Northern Ireland and following six and a half successful years moved to Montana State University in January 2016.